INTERNATIONAL PATENT: DEWPOINT THERAPEUTICS, INC. FILES APPLICATION FOR "MODULATORS OF BETA CATENIN AND USES THEREOF"

GENEVA, May 6 -- DEWPOINT THERAPEUTICS, INC. (451 D StreetSuite 104Boston, MA 02210) filed a patent application (PCT/US2025/051769) for "MODULATORS OF BETA CATENIN AND USES THEREOF" on Oct 21, 2025. With publication no. WO/2026/090104, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TALBOT, Adam (451 D StreetSuite 104Boston, MA 02210), DURAND-REVILLE, Thomas (451 D StreetSuite 104Boston, MA 02210)

Abstract: Provided are compounds of the Formula I: (I), or pharmaceutically acceptable salts thereof, which are useful for th...